Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Vigil Reports Increased Sales Bookings in First Quarter

Read more ››
By: Nasdaq / GlobenewsWire - 17 Aug 2019
Related companies:  Vigil Health Solutions Inc.

2019 Overview of the Increasing Use of Medical Imaging Modalities for Guidance and Navigation During Surgical Procedures and Treatments

DUBLIN, Aug. 16, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 17 Aug 2019

Savii Inc. Announces New Client Link Home Care out of NY

TAMPA, Fla., Aug. 16, 2019 /PRNewswire/ -- Link Home Care Services, cutting-edge LHCSA and CDPAP provider out of New York, selects Savii Inc. as their home care software platform. Their partnership formed due to shared values and desire to drive innovation in the home care industry.

Read more ››
By: PR Newswire Association LLC. - 17 Aug 2019

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: Nasdaq / GlobenewsWire - 16 Aug 2019
Related companies:  Apellis Pharmaceuticals, Inc.

Parent-Targeted Interventions in the Primary Care Setting Improve Parent Communications with Teens about Alcohol Use, Sexual Behavior

PHILADELPHIA, Aug. 16, 2019 /PRNewswire/ -- New research shows that brief parent-targeted interventions in the primary care setting can increase communication between parents and their teens about sexual and alcohol behavior. This method may serve as an important strategy for parents to influence... Read more ››

By: PR Newswire Association LLC. - 16 Aug 2019
Related companies:  Children's Hospital of Philadelphia

Oncopeptides Announces Acceptance of Data for Presentation at International Myeloma Workshop, September 12-15

STOCKHOLM, Aug. 16, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today the acceptance of an oral late breaking presentation providing updated melflufen data from the Phase 2 pivotal OP-106 HORIZON study as well as two poster presentations at the 17th International... Read more ››

By: PR Newswire Association LLC. - 16 Aug 2019

Immunoassay Markets, 2025 - Increasing Use of Immunoassays in Oncology

DUBLIN, Aug. 16, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 16 Aug 2019

Dr. Susan J. Littman, M.D., is recognized by Continental Who's Who

AMBLER, Pa., Aug. 16, 2019 /PRNewswire/ -- Dr. Susan J. Littman, M.D., is recognized by Continental Who's Who as a Top Doctor for her outstanding contributions in the field of Medicine. She currently serves as an Internist, Hematologist and Oncologist at Crozer Medical Center.

Read more ››
By: PR Newswire Association LLC. - 16 Aug 2019

China Precision Medicine Market, 2019-2029: Stakeholder-focused Strategies to Enable Global Partnerships and Overall Industry Growth

DUBLIN, Aug. 16, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 16 Aug 2019

CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device

MINNEAPOLIS, Aug. 16, 2019 /PRNewswire/ -- CVRx, Inc., a private medical device company, announced today that it has received Premarket Approval (PMA) from the United States Food and Drug Administration (FDA) to market its BAROSTIM NEO device for heart failure in the United States. The FDA's... Read more ››

By: PR Newswire Association LLC. - 16 Aug 2019
Related companies:  U.S. Food and Drug Administration | CVRx, Inc.

FDA approves new device to improve symptoms in patients with advanced heart failure

SILVER SPRING, Md., Aug. 16, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization... Read more ››

By: PR Newswire Association LLC. - 16 Aug 2019
Related companies:  U.S. Food and Drug Administration

AllianceRx Walgreens Prime Issues Updated List of New Specialty Drugs

ORLANDO, Fla., Aug. 16, 2019 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies... Read more ››

By: PR Newswire Association LLC. - 16 Aug 2019

Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2019

HOUSTON, Aug. 16, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its financial results for the second quarter... Read more ››

By: PR Newswire Association LLC. - 16 Aug 2019
Related companies:  Moleculin Biotech, Inc.

Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous CONTEPO™ (fosfomycin) for Injection

Read more ››
By: Nasdaq / GlobenewsWire - 16 Aug 2019
Related companies:  Nabriva Therapeutics plc

Announcement from Acarix's extra general meeting

Read more ››
By: Nasdaq / GlobenewsWire - 16 Aug 2019
Related companies:  Acarix AB

Auxly Reports Q2 2019 Financial Results and Subsequent Financing Activities of Over $200 Million

Read more ››
By: Nasdaq / GlobenewsWire - 16 Aug 2019

T2 Biosystems Expands Access to its Innovative Rapid Diagnostic Technologies to Australia, Fiji and New Zealand

Read more ››
By: Nasdaq / GlobenewsWire - 16 Aug 2019
Related companies:  T2 Biosystems, Inc.

Catalyst Biosciences to Present at the 2019 Hemophilia Drug Development Summit

Read more ››
By: Nasdaq / GlobenewsWire - 16 Aug 2019
Related companies:  Catalyst Biosciences

Forbes Recognizes PharmCo Rx for its Expertise in CBD Products

Read more ››
By: Nasdaq / GlobenewsWire - 16 Aug 2019

Protech Home Medical Receives Final Garnishee Order Absolute

Read more ››
By: Nasdaq / GlobenewsWire - 16 Aug 2019
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑